{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34462452", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "09"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "30"}], "Language": ["eng"], "ELocationID": ["17385", "10.1038/s41598-021-96429-x"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "30"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "The importance of the UGT1A1 variants in the development of osteopenia and osteoporosis in postmenopausal women.", "Pagination": {"StartPage": "17385", "MedlinePgn": "17385"}, "Abstract": {"AbstractText": ["The UDP-glucuronosyltransferase 1A1 (UGT1A1) is involved in the process of estrogen conjugation and elimination. The aim of the study was to analyze whether the UGT1A1 genetic variants are associated with the development of osteopenia and osteoporosis in postmenopausal women. The analysis of the rs4148323 (UGT1A1*6) and rs3064744 (UGT1A1*28) variants in the UGT1A1 gene was conducted using real-time PCR. A significant correlation was observed between the genotypes of the rs3064744 (UGT1A1*28) sequence variant and body mass in women with osteoporosis. The analysis of the Z-score values revealed that women with osteoporosis and carrying the 6/6 variant had the lowest Z-score values as compared to women with the 6/7 and the 7/7 variants (-\u20091.966\u2009\u00b1\u20090.242 vs. -\u20091.577\u2009\u00b1\u20090.125 and -\u20091.839\u2009\u00b1\u20090.233). In addition, the odds ratio for the investigated genotypes (6/6, 6/7, 7/7) indicated an increased risk for osteopenia and osteoporosis in women with the 7/7 homozygous genotype. The analysis of the frequencies of the GG, GA and AA genotypes of the rs4148323 UGT1A1 gene showed no statistically significant differences between the groups. Our analysis revealed that the UGT1A1 rs3064744 variant may affect the risk of developing osteoporosis in postmenopausal Polish women. The UGT1A1 rs4148323 variant is not directly associated with the development of osteopenia and osteoporosis."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Phytochemistry, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064, Plewiska, Poland. aniabogacz23@o2.pl."}], "LastName": "Bogacz", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics and Traumatology, Independent Public Clinical Hospital No. 1, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland."}], "LastName": "Kami\u0144ski", "ForeName": "Adam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630, Poznan, Poland."}], "LastName": "\u0141ochy\u0144ska", "ForeName": "Ma\u0142gorzata", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230, Szczecin, Poland."}], "LastName": "Uzar", "ForeName": "Izabela", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Independent Laboratory of Invasive Cardiology, Pomeranian Medical University in Szczecin, al. Powsta\u0144c\u00f3w Wlkp. 72, 70-111, Szczecin, Poland."}], "LastName": "Gor\u0105cy", "ForeName": "Jaros\u0142aw", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, Traumatology and Orthopaedic Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1, 71-252, Szczecin, Poland."}], "LastName": "Kotrych", "ForeName": "Daniel", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-535, Poznan, Poland."}], "LastName": "Seremak-Mrozikiewicz", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230, Szczecin, Poland."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, \u017bo\u0142nierska 48, 71-230, Szczecin, Poland."}], "LastName": "Czerny", "ForeName": "Bogus\u0142aw", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "EC 2.4.1.-", "NameOfSubstance": "UGT1A1 enzyme"}, {"RegistryNumber": "EC 2.4.1.17", "NameOfSubstance": "Glucuronosyltransferase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Alleles"}, {"QualifierName": ["genetics", "pathology"], "DescriptorName": "Bone Diseases, Metabolic"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Frequency"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": ["genetics"], "DescriptorName": "Glucuronosyltransferase"}, {"QualifierName": [], "DescriptorName": "Homozygote"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["genetics", "pathology"], "DescriptorName": "Osteoporosis"}, {"QualifierName": [], "DescriptorName": "Poland"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Genetic"}, {"QualifierName": [], "DescriptorName": "Postmenopause"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mu\u00d1oz M, Robinson K, Shibli-Rahhal A. Bone health and osteoporosis prevention and treatment. Clin. Obstet. Gynecol. 2020;63(4):770\u2013787. doi: 10.1097/GRF.0000000000000572.", "ArticleIdList": ["10.1097/GRF.0000000000000572", "33017332"]}, {"Citation": "Lorenc R, et al. Guidelines for the diagnosis and management of osteoporosis in Poland: Update 2017. Endokrynol. Pol. 2017;68(5):604\u2013609. doi: 10.5603/EP.2017.0062.", "ArticleIdList": ["10.5603/EP.2017.0062", "29168548"]}, {"Citation": "Johnston CB, Dagar M. Osteoporosis in older adults. Med. Clin. N. Am. 2020;104(5):873\u2013884. doi: 10.1016/j.mcna.2020.06.004.", "ArticleIdList": ["10.1016/j.mcna.2020.06.004", "32773051"]}, {"Citation": "Pothiwala P, Evans EM, Chapman-Novakofski KM. Ethnic variation in risk for osteoporosis among women: a review of biological and behavioral factors. J. Womens Health. 2006;15(6):709\u2013719. doi: 10.1089/jwh.2006.15.709.", "ArticleIdList": ["10.1089/jwh.2006.15.709", "16910903"]}, {"Citation": "Minkin MJ. Menopause: Hormones, lifestyle, and optimizing aging. Obstet. Gynecol. Clin. N. Am. 2019;46(3):501\u2013514. doi: 10.1016/j.ogc.2019.04.008.", "ArticleIdList": ["10.1016/j.ogc.2019.04.008", "31378291"]}, {"Citation": "Corrado A, Cici D, Rotondo C, Maruotti N, Cantatore FP. Molecular basis of bone aging. Int. J. Mol. Sci. 2020;21(10):3679. doi: 10.3390/ijms21103679.", "ArticleIdList": ["10.3390/ijms21103679", "PMC7279376", "32456199"]}, {"Citation": "Wolski H, et al. Polymorphism of bone morphogenetic protein (BMP2) and osteoporosis etiology. Ginekol. Pol. 2015;86:203\u2013209. doi: 10.17772/gp/2006.", "ArticleIdList": ["10.17772/gp/2006", "25920311"]}, {"Citation": "Kaleta B, et al. Toll-like receptor 4 gene polymorphism C1196T in Polish women with postmenopausal osteoporosis\u2014Preliminary investigation. Adv. Clin. Exp. Med. 2015;24(2):239\u2013243. doi: 10.17219/acem/22747.", "ArticleIdList": ["10.17219/acem/22747", "25931355"]}, {"Citation": "Wolski H, Drw\u0119ska-Matelska N, Seremak-Mrozikiewicz A. The role of Wnt/\u03b2-catenin pathway and LRP5 protein in metabolism of bone tissue and osteoporosis etiology. Ginekol. Pol. 2015;86:311\u2013314. doi: 10.17772/gp/2079.", "ArticleIdList": ["10.17772/gp/2079", "26117992"]}, {"Citation": "Jin H, Evangelou E, Ioannidis JP, Ralston SH. Polymorphisms in the 5\u2032 flank of COL1A1 gene and osteoporosis: Meta-analysis of published studies. Osteoporos. Int. 2011;22(3):911\u2013921. doi: 10.1007/s00198-010-1364-5.", "ArticleIdList": ["10.1007/s00198-010-1364-5", "PMC4696542", "20798928"]}, {"Citation": "Mohammadi Z, et al. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: A systematic review. J. Diabetes Metab. Disord. 2014;13(1):98. doi: 10.1186/s40200-014-0098-x.", "ArticleIdList": ["10.1186/s40200-014-0098-x", "PMC4215021", "25364703"]}, {"Citation": "Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology. 2002;181\u2013182:453\u2013456. doi: 10.1016/S0300-483X(02)00449-3.", "ArticleIdList": ["10.1016/S0300-483X(02)00449-3", "12505351"]}, {"Citation": "Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: Their role in drug metabolism and detoxification. Int. J. Biochem. Cell Biol. 2013;45(6):1121\u20131132. doi: 10.1016/j.biocel.2013.02.019.", "ArticleIdList": ["10.1016/j.biocel.2013.02.019", "23500526"]}, {"Citation": "Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenom. J. 2003;3(3):136\u2013158. doi: 10.1038/sj.tpj.6500171.", "ArticleIdList": ["10.1038/sj.tpj.6500171", "12815363"]}, {"Citation": "Court MH, et al. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica. 2012;42(3):266\u2013277. doi: 10.3109/00498254.2011.618954.", "ArticleIdList": ["10.3109/00498254.2011.618954", "21995321"]}, {"Citation": "Yokota M, et al. Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese women. Prz. Menopauzalny. 2015;14(3):161\u2013167.", "ArticleIdList": ["PMC4612551", "26528103"]}, {"Citation": "Ostrowska Z. Menopause, obesity, and bone status. Adv. Hyg. Exp. Med. 2009;63:39\u201346.", "ArticleIdList": ["19252463"]}, {"Citation": "Cifuentes M, et al. Bone turnover and body weight relationship differ in normal-weight compared with heavier postmenopausal women. Osteoporos. Int. 2003;14(2):116\u2013122. doi: 10.1007/s00198-002-1324-9.", "ArticleIdList": ["10.1007/s00198-002-1324-9", "PMC4042209", "12730781"]}, {"Citation": "Silva HG, Mendon\u00e7a LM, Concei\u00e7\u00e3o FL, Zahar SE, Farias ML. Influence of obesity on bone density in postmenopausal women. Arq. Bras. Endocrinol. Metabol. 2007;51(6):943\u2013949. doi: 10.1590/S0004-27302007000600008.", "ArticleIdList": ["10.1590/S0004-27302007000600008", "17934661"]}, {"Citation": "Dawson-Hughes B, Shipp C, Sadowski L, Dallal G. Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women. Calcif. Tissue Int. 1987;40(6):310\u2013314. doi: 10.1007/BF02556691.", "ArticleIdList": ["10.1007/BF02556691", "3111668"]}, {"Citation": "Nagant de Deuxchaisnes C, Devogelaer JP. Endocrinological status of postmenopausal osteoporosis. Clin. Rheum. Dis. 1986;12(3):559\u2013635. doi: 10.1016/S0307-742X(21)00572-5.", "ArticleIdList": ["10.1016/S0307-742X(21)00572-5", "3078776"]}, {"Citation": "Papakitsou EF, et al. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas. 2004;47(3):185\u2013193. doi: 10.1016/S0378-5122(03)00282-2.", "ArticleIdList": ["10.1016/S0378-5122(03)00282-2", "15036488"]}, {"Citation": "Reid IR. Obesity and osteoporosis. Ann. Endocrinol. 2006;67:125\u2013129. doi: 10.1016/S0003-4266(06)72567-7.", "ArticleIdList": ["10.1016/S0003-4266(06)72567-7", "16639362"]}, {"Citation": "Liu W, et al. Correlation between UGT1A1 polymorphism and neonatal hyperbilirubinemia of neonates in Wuhan. J. Huazhong Univ. Sci. Technol. Med. Sci. 2017;37(5):740\u2013743.", "ArticleIdList": ["29058288"]}, {"Citation": "Peng H, Duan Z, Pan D, Wen J, Wei X. UGT1A1 gene polymorphism predicts irinotecan-induced severe neutropenia and diarrhea in Chinese cancer patients. Clin. Lab. 2017;63(9):1339\u20131346.", "ArticleIdList": ["28879724"]}, {"Citation": "Jannin A, Hennart B, Adenis A, Chauffert B, Penel N. Life-threatening irinotecan-induced toxicity in an adult patient with alveolar rhabdomyosarcoma: The role of a UGT1A1 polymorphism. Case Rep. Oncol. Med. 2017;2017:2683478.", "ArticleIdList": ["PMC5634569", "29098099"]}, {"Citation": "Fujita K, Sparreboom A. Pharmacogenetics of irinotecan disposition and toxicity: A review. Curr. Clin. Pharmacol. 2010;5(3):209\u2013217. doi: 10.2174/157488410791498806.", "ArticleIdList": ["10.2174/157488410791498806", "20406168"]}, {"Citation": "Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc. Natl. Acad. Sci. USA. 1998;95(14):8170\u20138174. doi: 10.1073/pnas.95.14.8170.", "ArticleIdList": ["10.1073/pnas.95.14.8170", "PMC20948", "9653159"]}, {"Citation": "Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics. 1999;9(5):591\u2013599. doi: 10.1097/00008571-199910000-00006.", "ArticleIdList": ["10.1097/00008571-199910000-00006", "10591539"]}, {"Citation": "Akaba K, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: A common missense mutation among Japanese, Koreans and Chinese. Biochem. Mol. Biol. Int. 1998;46(1):21\u201326.", "ArticleIdList": ["9784835"]}, {"Citation": "Araki K, et al. Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer. Cancer Sci. 2006;97(11):1255\u20131259. doi: 10.1111/j.1349-7006.2006.00321.x.", "ArticleIdList": ["10.1111/j.1349-7006.2006.00321.x", "16965601"]}, {"Citation": "Mr\u00f3z A, Mazerska Z. Glucuronidation of antitumour therapeutics\u2014Detoxification, mechanism of resistance or prodrug formation? Adv. Hyg. Exp. Med. 2015;69:1462\u20131477.", "ArticleIdList": ["27259218"]}, {"Citation": "Trontelj J, Marc J, Zavratnik A, Bogataj M, Mrhar A. Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics. Br. J. Clin. Pharmcol. 2009;67(4):437\u2013444. doi: 10.1111/j.1365-2125.2009.03363.x.", "ArticleIdList": ["10.1111/j.1365-2125.2009.03363.x", "PMC2679107", "19371317"]}, {"Citation": "Niemira M, Wi\u015bniewska A, Mazerska Z. Polymorphism and the level of P450 gene xpression in xenobiotic metabolism. Postepy. Biochem. 2009;55(3):279\u2013289.", "ArticleIdList": ["19928584"]}, {"Citation": "Noworyta-Zi\u0119tara M, Miazgowski T, Krzy\u017canowska-\u015awiniarska B, Ogonowski J. Does obesity protect against osteoporosis? Endokrynologia Oty\u0142o\u015b\u0107 i Zaburzenia Przemiany Materii. 2008;4:69\u201377."}, {"Citation": "Reid IR. Relationships between fat and bone. Osteoporos. Int. 2008;19(5):595\u2013606. doi: 10.1007/s00198-007-0492-z.", "ArticleIdList": ["10.1007/s00198-007-0492-z", "17965817"]}, {"Citation": "Ahmed LA, Schirmer H, Berntsen GK, F\u00f8nneb\u00f8 V, Joakimsen RM. Features of the metabolic syndrome and the risk of non-vertebral fractures: The Troms\u00f8 study. Osteoporos. Int. 2006;17(3):426\u2013432. doi: 10.1007/s00198-005-0003-z.", "ArticleIdList": ["10.1007/s00198-005-0003-z", "16437192"]}, {"Citation": "Bosma PJ, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 1995;333(18):1171\u20131175. doi: 10.1056/NEJM199511023331802.", "ArticleIdList": ["10.1056/NEJM199511023331802", "7565971"]}, {"Citation": "Moczulski D, Trombik M, Gawlik B, G\u00f3rczy\u0144ska-Kosiorz S, Grzeszczak W. Sensitivity of genetic testing for Gilbert syndrome in Polish population. Gastroenterol. Rev. 2007;14:9\u201311."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "27"}, {"Year": "2021", "Month": "8", "Day": "3"}, {"Year": "2021", "Month": "8", "Day": "31", "Hour": "6", "Minute": "7"}, {"Year": "2021", "Month": "9", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["34462452", "PMC8405802", "10.1038/s41598-021-96429-x", "10.1038/s41598-021-96429-x"]}}], "PubmedBookArticle": []}